Health CanadaGeneral Alert
The use of Tarceva (erlotinib) in patients with moderate hepatic impairment and advanced solid tumours - For Health Professionals
Published: December 17, 2008Recall ID: 24296Category: generalCountry: Canada
Safety AlertHealth CanadaCanada
CanadaThe use of Tarceva (erlotinib) in patients with moderate hepatic impairment and advanced solid tumours - For Health Professionals
Recalling Firm: Marketed health products
Product Description & Identification
The use of Tarceva (erlotinib) in patients with moderate hepatic impairment and advanced solid tumours - For Health Professionals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24296 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/use-tarceva-erlotinib-patients-moderate-hepatic-impairment-and-advanced-solid-tumours |
| Title | The use of Tarceva (erlotinib) in patients with moderate hepatic impairment and advanced solid tumours - For Health Professionals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2008-12-17 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - The use of Tarceva (erlotinib) in patients with moderate hepatic impairment and advanced solid tumours - For Health Professionals Check if your household is affected: https://therecallfile.com/recalls/the-use-of-tarceva-erlotinib-in-patients-with-moderate-hepatic-impairm/CANADA-24296
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Featured on Product Hunt
Help support our public safety mission and check out our community launch.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordThe use of Tarceva (erlotinib) in patients with moderate hepatic impairment and advanced solid tumours - For Health Professionals
Related Recalls
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018088 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018088 -
Tires
—TC
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018288 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018288 -
Airbag
—TC
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018409 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018409 -
Airbag
—TC